Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024;24(14):1185-1211.
doi: 10.2174/0115680266286460240220073334.

Microfluidics-mediated Liposomal Nanoparticles for Cancer Therapy: Recent Developments on Advanced Devices and Technologies

Seyed Morteza Naghib  1 , Kave Mohammad-Jafari  1
Affiliations
Review

Microfluidics-mediated Liposomal Nanoparticles for Cancer Therapy: Recent Developments on Advanced Devices and Technologies

Seyed Morteza Naghib et al. Curr Top Med Chem. 2024.

Abstract

Liposomes, spherical particles with phospholipid double layers, have been extensively studied over the years as a means of drug administration. Conventional manufacturing techniques like thin-film hydration and extrusion have limitations in controlling liposome size and distribution. Microfluidics enables superior tuning of parameters during the self-assembly of liposomes, producing uniform populations. This review summarizes microfluidic methods for engineering liposomes, including hydrodynamic flow focusing, jetting, micro mixing, and double emulsions. The precise control over size and lamellarity afforded by microfluidics has advantages for cancer therapy. Liposomes created through microfluidics and designed to encapsulate chemotherapy drugs have exhibited several advantageous properties in cancer treatment. They showcase enhanced permeability and retention effects, allowing them to accumulate specifically in tumor tissues passively. This passive targeting of tumors results in improved drug delivery and efficacy while reducing systemic toxicity. Promising results have been observed in pancreatic, lung, breast, and ovarian cancer models, making them a potential breakthrough in cancer therapy. Surface-modified liposomes, like antibodies or carbohydrates, also achieve active targeting. Overall, microfluidic fabrication improves reproducibility and scalability compared to traditional methods while maintaining drug loading and biological efficacy. Microfluidics-engineered liposomal formulations hold significant potential to overcome challenges in nanomedicine-based cancer treatment.

Keywords: Cancer therapy; Drug delivery; Liposome; Microfluidics; Nanoparticles; Targeting..

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Wang Q.; Xu W.; Li Q.; He C.; Liu Y.; Liu J.; Wang R.; Wu J.; Xiang D.; Chen C.; Coaxial electrostatic spray-based preparation of localization missile liposomes on a microfluidic chip for targeted treatment of triple-negative breast cancer. Int J Pharm 2023,643,123220 - DOI - PubMed
    1. Allen T.M.; Cullis P.R.; Liposomal drug delivery systems: From concept to clinical applications. Adv Drug Deliv Rev 2013,65(1),36-48 - DOI - PubMed
    1. van der Koog L.; Gandek T.B.; Nagelkerke A.; Liposomes and extracellular vesicles as drug delivery systems: A comparison of composition, pharmacokinetics, and functionalization. Adv Healthc Mater 2022,11(5),2100639 - DOI - PubMed
    1. Vishvakrama P.; Sharma S.; Liposomes: An overview. J Drug Deliv Ther 2014,47-55
    1. Sivasankar M.; Katyayani T.; Liposomes: The future of formulations. Int J Res Pharm Chem 2011,1(2),259-267

LinkOut - more resources